SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-15-005790
Filing Date
2015-07-29
Accepted
2015-07-29 17:03:54
Documents
10
Period of Report
2015-09-23
Effectiveness Date
2015-07-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A ctic-def14a_20150923.htm DEF 14A 2572773
2 GRAPHIC g20150729200708727619.jpg GRAPHIC 1197
3 GRAPHIC g20150729200708727620.jpg GRAPHIC 1237
4 GRAPHIC g20150729200848772624.jpg GRAPHIC 75741
5 GRAPHIC g20150729200708742621.jpg GRAPHIC 1192
6 GRAPHIC g20150729200833835622.jpg GRAPHIC 3654
7 GRAPHIC g20150729200848210623.jpg GRAPHIC 83599
8 GRAPHIC g20150729200707570617.jpg GRAPHIC 3654
9 GRAPHIC g20150729200708711618.jpg GRAPHIC 1169
10 GRAPHIC g20150729200707321616.jpg GRAPHIC 4748
  Complete submission text file 0001564590-15-005790.txt   2818158
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-12465 | Film No.: 151013481
SIC: 2834 Pharmaceutical Preparations